The association between cancer and PH: A tale of two diseases

4 May 2022

A PVRI 2022 Digital webinar

Presentations

  • Cancer induced PH: Embolism as a major inducer, Timothy Morris
  • Cancer induced PH: Microenvironmental cancer niche as a major inducer, Rajkumar Savai 
  • Cancer therapies induced PH, Frédéric Perros
  • Cancer related signalling mechanisms underlying PH development, Olivier Boucherat 
  • FOXO3: A new potential therapeutic target in pulmonary arterial hypertension, Yann Grobs
  • Non-invasive surrogate markers of PH are associated with poor survival in lung cancer patients, Michael Cekay

Poll

Start of webinar poll

1. N/A

 

2. Talk 2: PH impacts the lung cancer prognosis and survival

Agree - 100%

Disagree - 0%

 

3. Talk 3: Current animal models of pulmonary hypertension, acute and hyperproliferative in nature, do not predict the effect of anti-cancer therapies in the setting

Yes - 100%

No - 0%

 

4. Talk 4: Should we focus on signaling pathways identified in cancer to find new actionable targets in PAH?

Yes - 100%

No - 0%

 

5. Talk 5: TFP is an antagonist of calmodulin and has a cardioprotective effect on left ventricle. In PAH, do you think TFP treatment could improve hemodynamic parameters by playing a role on lung and right ventricle maladaptive remodeling?

Yes - 75%

No - 25%

 

Talk 6: Lung cancer patients with pulmonary hypertension may profit from guidelines based pulmonary hypertension therapy.

Agree - 75%

Disagree - 25%

Speakers & Moderators

Timothy Morris, University of California San Diego, USA
Rajkumar Savai, Justus Liebig University Giessen, Germany
Frédéric Perros, The Inserm U999, France
Olivier Boucherat, University Institute of Cardiology and Pneumology of Quebec, Canada
Yann Grobs, Laval University, Canada
Michael Cekay, Justus Liebig University Giessen, Germany
Share:

Other materials on this topic

31 March 2022

Ageing and pulmonary hypertension: an endemic at the horizon?

Webinar presentations: Age-dependent prevalence of PH in the general population, Harm Jan Bogaard, Senescence mechanisms and pulmonary vascular aging, Serge Adnot, Metabolic Syndrome and obesity leads to age-related PH, Imad Al Ghouleh, Genetics and epigenetics in age-related PH, Stephen Archer, Right heart catheterization is underused in elderly patients suspected of pulmonary hypertension, Samara Jansen

PVRI Digital Webinar Series
17 February 2022

Tobacco smoking as risk for pulmonary hypertension

Pulmonary hypertension (PH) is a multifactorial chronic pulmonary disease. During the past decade, various pathophysiological pathways eventually leading to progressive pulmonary vascular remodelling have been detected...

IDDI Workstream or Task Force Learning
Additional comments are available to members. Login or register to become a member today
RegisterorLogin to view